[ad_1] Article content BAAR, Switzerland — Stallergenes Greer, a leading global healthcare company specialising in allergen immunotherapy (AIT), announced today that it has signed global agreements with Nestlé to harness…
Tag: immunotherapy
New Treatment for Bladder Cancer Offers This Biotech a Second Chance
[ad_1] UroGen hopes to have success with a new treatment after its first drug was a commercial flop. [ad_2] Source link
Drug Shortages Stem From Quality Problems in Indian Factories
[ad_1] Shoddy conditions at factories in India have sickened Americans and stoked a chemotherapy-drug shortage for cancer patients, raising calls for a more-resilient generic-drug supply. [ad_2] Source link
Stallergenes Greer Showcases Clinical Relevance and Persisting Benefits of Its Allergen Immunotherapy Treatments at 2023 EAACI Congress
[ad_1] Article content BAAR, Switzerland — Stallergenes Greer, a leading global healthcare company specialising in allergen immunotherapy (AIT), will be hosting a company-sponsored symposium entitled “Patient’s perspective: A must have…
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
[ad_1] Health In temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved [ad_2] Source link
McCormick Engineering Events | Monthly Seminar on Physical Genomics – Abnormal Mechanics in Brain Tumors: Implications for Immunotherapy
[ad_1] Events To filter event listings, choose your filter options below and click submit at the bottom of the form. eg. John Smith, company day — comma separated …
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023
[ad_1] FLORHAM PARK, N.J., March 30, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious…
Moderna’s mRNA Cancer Vaccine Shows Promise in Preliminary Study
[ad_1] Business Health Care Health The shot combined with a Merck immunotherapy reduced the risk of relapse in people with skin cancer in a study, Moderna said [ad_2] Source link